Therefore, our case-control study aims to establish the association of SLC1A2 rs4755404 genetic polymorphism with METH-induced symptoms and dependence, which is a move forward regarding personalizing medicine in the Malaysian population. The gene discussed is SLC1A2; the disease is substance dependence.